Zydus Lifesciences

BSE : 532321 | NSE : ZYDUSLIFE

Industry : Pharmaceuticals | ISIN : INE010B01027 | FreeFloat : 30.00% | FnO : Yes | LotSize : 1800


Intellectual Capital (IC)21,979.85
Net Worth (NW)18,767.50
Intrinsic Worth (IW)40,747.35
Market Cap (MC)39,162.18
Economic Value Added-118.90
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)53.94%
IC Gross Margin (EBITDA/IC)16.44%
IC Net Margin (NPT/IC)8.76%
Knowledge Turnover (Sales/IC)0.73
Market to Intrinsic Value (MC/IW)0.96

As OfIntrinsic ValueMarket Price
30 Sep 2022Rs. 402.56Rs. 386.90
29 Nov 2022 ---- Rs. 405.35
5.40     1.33%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 400.88BuyHold
KB > 50% : Yes50 DMA : Rs. 407.08
0 < M2IV < 1 : YesVol-Price trend : Rising

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Dec-19
C
3638.10
3658.20
711.70
537.60
457.10
373.90
356.70
Mar-20
C
3752.10
3796.40
783.00
604.50
522.00
391.90
193.90
Jun-20
C
3639.90
3662.40
837.90
661.10
593.40
454.00
463.80
Sep-20
C
3820.00
3847.50
758.90
579.90
534.20
473.40
554.70
Dec-20
C
3795.60
3823.10
834.40
654.00
627.20
527.20
543.70
Mar-21
C
3846.70
3806.40
741.90
553.30
530.00
679.00
673.90
Jun-21
C
4025.40
4057.00
964.60
781.90
754.60
587.20
536.10
Sep-21
C
3784.80
3838.10
914.10
729.30
699.20
515.80
506.20
Dec-21
C
3655.00
3715.80
813.30
630.10
599.00
500.40
513.80
Mar-22
C
3863.80
3942.90
801.40
616.00
577.50
397.40
327.60
Jun-22
C
4072.70
4138.60
921.00
740.30
706.00
518.30
379.00
Sep-22
C
4134.70
4179.10
874.50
692.70
657.60
522.50
437.30
* C - Consolidated, S - Standalone